Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
The BioNTech SE ADR BNTX slid 2.69% to $112.51 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 and the ...
The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...
BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...
On Thursday, Aug. 22, the United States Food and Drug Administration (FDA) approved and authorized updated versions of mRNA ...
It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.
According to the FDA, unvaccinated individuals 6 months through 4 years of age can receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated, ...
Targeting the KP.2 strain is expected to provide better protection against COVID-19 based on current data. The 2024-2025 mRNA COVID-19 vaccines will include a monovalent component that corresponds to ...
The summer surge of COVID-19 has been decreasing in Sonoma County in early September, but the county’s health officer warns ...
The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...
Fintel reports that on September 17, 2024, Jefferies upgraded their outlook for BioNTech SE - Depositary Receipt () (NasdaqGS ...